Survival analysis revealed that cancer patients with a mutation in NUDCD1 had a significantly worse DFS and PFS than the patients without NUDCD1 mutations (Figure 4C) and there was no significant difference between DSS and OS (Supplementary Figure 8A). The gene discussed is NUDCD1; the disease is cancer.